NARI

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Inari Medical Inc

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.
CEO
Employees
456
Headquarters

News

Inari Medical, Inc. (NARI) Investors: July 12, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
May 23, 2024 20:45pm

RADNOR, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Inari Medical, Inc. (“Inari Medical”) ( NASDAQ: NARI ) on behalf of investors who purchased or acquired Inari Medical common stock between February 24, 2022 through February 28, 2024, inclusive (the “Class Period”). The action charges Inari Medical with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects. As a result of Inari Medical’s materially misleading statements and omissions to the public, Inari Medical’s investors have suffered significant losses.


Source:GlobeNewswire
Shareholders that lost money on Inari Medical, Inc.(NARI) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
May 23, 2024 09:45am

NEW YORK, May 23, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Inari Medical, Inc. ("Inari Medical" or the "Company") (NASDAQ: NARI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Inari Medical investors who…


Source:PR Newswire
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Inari Medical, Inc. with Losses to Contact the Firm
May 22, 2024 16:30pm

The Schall Law Firm Encourages Investors in Inari Medical, Inc. with Losses to Contact the Firm


Source:GlobeNewswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NARI
May 21, 2024 23:45pm


Source:Kwhen Finance
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Inari Medical, Inc. (NARI)
May 21, 2024 17:34pm

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 12, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Inari Medical, Inc. (“Inari” or the “Company”) (NASDAQ: NARI) common stock between February 24, 2022 through February 28, 2024, inclusive (the “Class Period”). If you suffered Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Inari Medical, Inc. (NARI)
May 20, 2024 17:19pm

Law Offices of Howard G. Smith reminds investors of the upcoming July 12, 2024 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Inari Medical, Inc. (“Inari” or the “Company”) (NASDAQ: NARI) common stock between February 24, 2022 through February 28, 2024, inclusive (the “Class Period”). Investors suffering losses on their Inari investments Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sprout Social, and Inari and Encourages Investors to Contact the Firm
May 19, 2024 01:00am

NEW YORK, May 18, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sprout Social, Inc. (NASDAQ: SPT), and Inari Medical, Inc. (NASDAQ: NARI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.


Source:GlobeNewswire
Insider Sale: Director William Hoffman Sells 40,000 Shares of Inari Medical Inc (NARI)
May 18, 2024 06:36am

Insider Sale: Director William Hoffman Sells 40,000 Shares of Inari Medical Inc (NARI)


Source:GuruFocus
DEADLINE ALERT for SPT, NARI, and UNH: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
May 17, 2024 16:08pm

LOS ANGELES, May 17, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.


Source:GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc. (NARI) Investors
May 16, 2024 22:39pm

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Inari Medical, Inc. (“Inari” or the “Company”) (NASDAQ: NARI) common stock between February 24, 2022 through February 28, 2024, inclusive (the “Class Period”). Inari investors have until Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online